客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 2/2 每页显示数量
RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma.
Authors: Huang H,,, Chen T,,, Zhou Y,,, Geng L, Shen T, Zhou L,,, Zheng S,,.
Journal: Int J Med Sci
PubMed ID: 30588188
Doi: 10.7150/ijms.28289
Products & Services: Catalog Antibody   
CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets.
Authors: Aldhamen YA, Rastall DPW, Chen W, Seregin SS, Pereira-Hicks C, Godbehere S, Kaminski NE, Amalfitano A.
Journal: Vaccine.
PubMed ID: 27151882
Doi: 10.1016/j.vaccine.2016.04.068
Human VE-Cadherin Fusion Protein as an Artificial Extracellular Matrix Enhancing the Proliferation and Differentiation Functions of Endothelial Cell.
Authors: Xu K, Shuai Q, Li X, Zhang Y, Gao C, Cao L, Hu F, Akaike T, Wang JX, Gu Z, Yang J.
Journal: Biomacromolecules.
PubMed ID: 26859785
Products & Services: Catalog Antibody   
  • « 上一页
  • 1
  • 2
  • 下一页 »

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*